This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Piyathilake, C. J. Articles by Grizzle, W. E. Search for Related Content PubMed PubMed Citation Articles by Piyathilake, C. J. Articles by Grizzle, W. E.

Differential Expression of Growth Factors in Squamous Cell Carcinoma and Precancerous Lesions of the Lung¹

Departments Nutrition Sciences [C. J. P., D. C. H.] Pathology [A. R. F., U. M., W. C. B., W. E. G.], Heidi Weiss Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama 35294

Purpose: This study was conducted to evaluate the clinical significance of the localization of epidermal growth factor receptor (EGF-r), transforming growth factor (TGF)-, and erbB-2 in the development, progression and prognosis of squamous cell cancers (SCCs) of the lung.

Experimental Design: The localization of EGF-r, TGF-, and erbB-2 was evaluated immunohistochemically in 60 archival specimens of SCC of the lung and in 60 lung specimens without cancer. To clarify the patterns of expression of EGF-r in these tumors, the patterns of expression of EGF-r in cells in culture were monitored after challenging normal human bronchial epithelial and SCC cell lines with either EGF or TGF- at physiological concentrations.

Results and Conclusions: The expression of EGF-r, erbB-2, and TGF- were significantly higher in SCC and associated precancerous lesions than in the normal bronchial epithelium and hyperplastic lesions of noncancer specimens. A statistically significant stepwise increase in expression from uninvolved bronchial epithelium to precancerous lesions to SCC was observed with EGF-r and TGF-. The localization of EGF-r in the cytoplasm (P = 0.04), but not in the membrane (P = 0.20), of SCCs was significantly associated with poor overall survival of subjects. To demonstrate the biological relevance of cytoplasmic expression of EGF-r, we noted that there was a prompt reduction in the membrane expression and a concomitant increase in cytoplasmic expression of EGF-r after adding either EGF or TGF- to the cell culture medium. Overall, the study identified an involvement of EGF-r and TGF- in the development of SCCs. The prognostic importance of EGF-r expression in the cytoplasm of lung cancer probably is an indication of the prognostic importance of trafficking of the EGF-r receptor between the Golgi apparatus and cell membranes and of internalization of EGF-r after an interaction with one of the EGF-r ligands at the cellular membrane surface.

This article has been cited by other articles:

				P. S. Hodkinson, A. MacKinnon, and T. Sethi Targeting Growth Factors in Lung Cancer Chest, May 1, 2008; 133(5): 1209 - 1216. [Abstract] [Full Text] [PDF]

				D. T. Merrick, J. Kittelson, R. Winterhalder, G. Kotantoulas, S. Ingeberg, R. L. Keith, T. C. Kennedy, Y. E. Miller, W. A. Franklin, and F. R. Hirsch Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2281 - 2288. [Abstract] [Full Text] [PDF]

				H Nakamura, N Kawasaki, M Taguchi, and K Kabasawa Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis Thorax, February 1, 2006; 61(2): 140 - 145. [Abstract] [Full Text] [PDF]

				W. E. Grizzle, D. G. Bostwick, H. Burke, O. W. Tawfik, D. McGregor, J. Cohn, and R. Lieberman Biomarkers in Prostate Cancer Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 196 - 204. [Full Text] [PDF]

				G. V. Scagliotti, G. Selvaggi, S. Novello, and F. R. Hirsch The Biology of Epidermal Growth Factor Receptor in Lung Cancer Clin. Cancer Res., June 15, 2004; 10(12): 4227S - 4232S. [Abstract] [Full Text] [PDF]

				G. Giaccone, J. L. Gonzalez-Larriba, A. T. van Oosterom, R. Alfonso, E. F. Smit, M. Martens, G. J. Peters, W. J. F. van der Vijgh, R. Smith, S. Averbuch, et al. Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors Ann. Onc., May 1, 2004; 15(5): 831 - 838. [Abstract] [Full Text] [PDF]

				G. Selvaggi, S. Novello, V. Torri, E. Leonardo, P. De Giuli, P. Borasio, C. Mossetti, F. Ardissone, P. Lausi, and G. V. Scagliotti Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer Ann. Onc., January 1, 2004; 15(1): 28 - 32. [Abstract] [Full Text] [PDF]

				F. R. Hirsch, M. Varella-Garcia, P. A. Bunn Jr, M. V. Di Maria, R. Veve, R. M. Bremnes, A. E. Baron, C. Zeng, and W. A. Franklin Epidermal Growth Factor Receptor in Non-Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis J. Clin. Oncol., October 15, 2003; 21(20): 3798 - 3807. [Abstract] [Full Text] [PDF]

				A-P. Meert, J-M. Verdebout, B. Martin, V. Ninane, F. Feoli, and J-P. Sculier Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions Eur. Respir. J., April 1, 2003; 21(4): 611 - 615. [Abstract] [Full Text] [PDF]

				C. J. Piyathilake and G. L. Johanning Cellular Vitamins, DNA Methylation and Cancer Risk J. Nutr., August 1, 2002; 132(8): 2340S - 2344. [Abstract] [Full Text] [PDF]